FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
August 16, 2018 08:30 ET
|
SPR Therapeutics, Inc.
SPRINT® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy CLEVELAND, Aug. 16, 2018 (GLOBE...
MossRehab First in Northeast to Offer Patients New Peripheral Nerve Stimulation Therapy for Relief of Post-Stroke Shoulder Pain
October 30, 2017 14:26 ET
|
MossRehab
Philadelphia, PA, Oct. 30, 2017 (GLOBE NEWSWIRE) -- MossRehab, one of the country’s leading rehabilitation institutes in Elkins Park, Pa, (and part of Einstein Healthcare Network) is now offering...
SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors
March 21, 2017 09:33 ET
|
SPR Therapeutics, LLC
CLEVELAND, March 21, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, LLC, a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and acute pain,...